eCTD Press Release from Diamond BioPharm
Diamond BioPharm Limited, announce a cutting edge first. As well as the submission of a Marketing Application for a Gene Therapy Product in December 2009 - on behalf of Amsterdam Molecular Therapeutics, a leading company in the development of gene-based therapies - the dossier is also in eCTD format. Maureen Graham, founder of Diamond BioPharm Limited said that it was a major achievement for both companies and is both proud and honoured that Diamond BioPharm Limited has had an opportunity to be part of this innovative project.
Important facts:
